| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $357.5M | +2.1% |
| Cost of Revenue | $244.0M | +6.1% |
| Gross Profit | $113.5M | -5.6% |
| R&D Expense | $56.1M | +19.3% |
| SG&A Expense | $85.4M | -5.4% |
| Operating Income | -$37.0M | -14.8% |
| Pre-tax Income | -$40.3M | -28.1% |
| Income Tax | $964K | -70.0% |
| Net Income | -$41.3M | -19.0% |
| EPS (Basic) | -$1.47 | -13.1% |
| EPS (Diluted) | -$1.47 | -13.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.3M | -26.4% |
| Inventory | $94.3M | +65.7% |
| Current Assets | $291.2M | +35.5% |
| Total Assets | $373.2M | +44.8% |
| Current Liabilities | $201.5M | +122.8% |
| Long-term Debt | $24.4M | — |
| Total Liabilities | $234.6M | +86.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | -253.1% |
| Capital Expenditures | $4.5M | -18.9% |
| Investing Cash Flow | -$28.0M | -195.4% |
| Financing Cash Flow | $64.8M | +172.4% |
| Free Cash Flow | -$55.1M | -176.8% |
| Stockholders' Equity |
| $138.6M |
| +5.1% |